Beyond China: 3 Indian pharma stocks winning the global API war

APIs are a critical component in pharma manufacturing and nearly 65-70% of supplies in India come from China. The government is keen on local production of APIs to ensure orderly supply to the Indian pharma industry. API manufacturers’ trade at a P/E of over 69. These players have rich valuations on account of their critical role.